MX9505064A - Composicion farmaceutica, aplicable oralmente. - Google Patents

Composicion farmaceutica, aplicable oralmente.

Info

Publication number
MX9505064A
MX9505064A MX9505064A MX9505064A MX9505064A MX 9505064 A MX9505064 A MX 9505064A MX 9505064 A MX9505064 A MX 9505064A MX 9505064 A MX9505064 A MX 9505064A MX 9505064 A MX9505064 A MX 9505064A
Authority
MX
Mexico
Prior art keywords
composition
pharmaceutical composition
amino acid
water
used pharmaceutical
Prior art date
Application number
MX9505064A
Other languages
English (en)
Inventor
Winfried Jettka
Benedikt Gajdos
Manrred Duerr
Original Assignee
Rhone Poulenc Rorer Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Gmbh filed Critical Rhone Poulenc Rorer Gmbh
Publication of MX9505064A publication Critical patent/MX9505064A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe una composicion farmacéutica, oralmente aplicable, por la que la composicion solida contiene por lo menos un ingrediente activo antiácido y/o por lo menos un antagonista del receptor H2, por lo menos un desintegrante, así como también por lo menos un ingrediente adicional farmacéutico, usual. Además, la composicion contiene por lo menos un ingrediente que acelera la descomposicion de la composicion en la boca o en un líquido, por lo que el ingrediente es un aminoácido soluble en agua, un derivado de aminoácido soluble en agua y/o una sal de aminoácido soluble en agua.
MX9505064A 1994-12-10 1995-12-05 Composicion farmaceutica, aplicable oralmente. MX9505064A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4444052A DE4444052A1 (de) 1994-12-10 1994-12-10 Pharmazeutische, oral anwendbare Zubereitung

Publications (1)

Publication Number Publication Date
MX9505064A true MX9505064A (es) 1997-01-31

Family

ID=6535487

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9505064A MX9505064A (es) 1994-12-10 1995-12-05 Composicion farmaceutica, aplicable oralmente.

Country Status (10)

Country Link
US (1) US6024987A (es)
EP (1) EP0715846A1 (es)
JP (1) JPH08208521A (es)
KR (1) KR100408587B1 (es)
AU (1) AU698749B2 (es)
CA (1) CA2164776C (es)
DE (1) DE4444052A1 (es)
MX (1) MX9505064A (es)
TW (1) TW457093B (es)
ZA (1) ZA9510428B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
EP1150918B1 (en) 1999-02-03 2004-09-15 Biosante Pharmaceuticals, Inc. Method of manufacturing therapeutic calcium phosphate particles
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
EP1242057A2 (en) * 1999-11-02 2002-09-25 DepoMed, Inc. Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
DE19962251A1 (de) * 1999-12-22 2001-09-06 Hermes Fabrik Pharm Praeparate Lutschtablette
JP2001278812A (ja) * 2000-03-27 2001-10-10 Kyoto Pharmaceutical Industries Ltd 錠剤用崩壊剤及びこれを用いた錠剤
WO2002048276A1 (de) * 2000-12-13 2002-06-20 Henkel Kommanditgesellschaft Auf Aktien Bindemittelagglomerat, verfahren zu dessen herstellung und dessen verwendung
WO2006073503A1 (en) * 2001-02-27 2006-07-13 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles for use in inhibiting expression of a gene
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
WO2003041698A1 (fr) * 2001-11-13 2003-05-22 Kyowa Hakko Kogyo Co., Ltd. Comprimes contenant des acides amines se desintegrant rapidement dans la cavite buccale et procede de fabrication de ces comprimes
US20030219501A1 (en) * 2002-05-24 2003-11-27 Day Charles E. All-natural antacid composition
US20040213838A1 (en) * 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
US20050220865A1 (en) * 2004-04-02 2005-10-06 Koleng John J Compressed composition comprising magnesium salt
CA2586035A1 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
JP5110810B2 (ja) * 2005-06-28 2012-12-26 上野製薬株式会社 打錠用糖アルコール粉末組成物
EP1992345A4 (en) * 2006-03-09 2010-07-28 Espinoza Abdala Leopoldo De Je SYNERGISTIC COMBINATION OF H2 RECEPTORS, INERT SILICONE INHIBITORS AND HYDROXYMAGNESIUM ALUMINATE COMPLEX
WO2009095210A1 (en) * 2008-01-31 2009-08-06 Bayer Consumer Care Ag Composition comprising an antacid and a h2-antagonists
ES2357209B1 (es) * 2009-05-26 2011-12-07 Fundacion Universitaria San Pablo-Ceu Composición farmacéutica sólida a base de famotidina contra la hipersecreción gástrica y otras enfermedades relacionadas, con mayor eficacia sinérgica y más rápida actuación.
MX2012002789A (es) * 2009-09-08 2012-06-01 Kyowa Chem Ind Co Ltd Tableta antiacida y laxante.
RU2013148719A (ru) * 2013-10-31 2015-05-10 Геннадий Гильфанович Галимов Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата
WO2018144771A2 (en) * 2017-02-02 2018-08-09 Water Pik, Inc. Tablet including abrasive for dental cleaning

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE534529A (es) * 1954-01-28
JPS60161915A (ja) * 1984-02-01 1985-08-23 Sato Seiyaku Kk 制酸剤含有内用液剤
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
CA2128821A1 (en) * 1993-07-27 1995-01-28 Dilip J. Gole Freeze-dried pharmaceutical dosage form and process for separation thereof
JP4683936B2 (ja) * 2005-01-26 2011-05-18 三洋電機株式会社 空気調和装置

Also Published As

Publication number Publication date
ZA9510428B (en) 1996-06-18
JPH08208521A (ja) 1996-08-13
KR100408587B1 (ko) 2004-03-04
CA2164776C (en) 2006-08-15
CA2164776A1 (en) 1996-06-11
US6024987A (en) 2000-02-15
AU698749B2 (en) 1998-11-05
KR960021061A (ko) 1996-07-18
TW457093B (en) 2001-10-01
DE4444052A1 (de) 1996-06-13
AU3794795A (en) 1996-06-20
EP0715846A1 (de) 1996-06-12

Similar Documents

Publication Publication Date Title
MX9505065A (es) Composicion farmaceutica, aplicable oralmente.
MX9505064A (es) Composicion farmaceutica, aplicable oralmente.
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
BG100946A (en) New amino acid derivatives, method for their preparation and pharmaceutical compositions containing them
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
MX9706449A (es) Composicion farmaceutica para compuestos de piperidinalcanol.
YU22399A (sh) Čvrsti farmaceutski sastavi koji obuhvataju ciklosporin i anjonsko površinski-aktivno sredstvo
MX9504034A (es) Formas de administracion medicamentosas que contienen acido tioctico, o sales solidas del acido tioctico de liberacion y biodisponibilidad mejoradas.
HRP980163B1 (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole -3-carboxamide derivative, its salts and their solvates
NZ506188A (en) A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
BG105257A (en) New oral formulation for 5-ht4 agonists or antagonists
CA2270177A1 (en) Transdermal administration of ment
PL320560A1 (en) Pharmaceutic composition
GEP20063719B (en) Prevention of Migraine Recurrence
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
PL329036A1 (en) Inclusive compounds of diclophenac and cyclodextrin
MY122477A (en) Sertraline oral concentrate
BG106151A (en) Pharmaceutical complex
MY118175A (en) Crystalline pharmaceutical product
CY2499B1 (en) Use of nk-1 receptor antagonists for treating stress disorders.
BG104452A (en) New derivatives of the methylenebisphosphonic acid
MY117156A (en) Pharmaceutical composition for oral administration
MY152490A (en) New oral formulation